[HTML][HTML] Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived …
M Cioce, MR Fumagalli, S Donzelli, F Goeman… - Journal of Experimental …, 2023 - Springer
Abstract Background Approximately 20–50% of patients presenting with localized colorectal
cancer progress to stage IV metastatic disease (mCRC) following initial treatment and this is …
cancer progress to stage IV metastatic disease (mCRC) following initial treatment and this is …
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids
M Cioce, M Fumagalli, S Donzelli… - … OF EXPERIMENTAL & …, 2023 - iris.uniroma1.it
Abstract Approximately 20-50% of patients presenting with localized colorectal cancer
progress to stage IV metastatic disease (mCRC) following initial treatment and this is a major …
progress to stage IV metastatic disease (mCRC) following initial treatment and this is a major …
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids
M Cioce, MR Fumagalli, S Donzelli, F Goeman… - … OF EXPERIMENTAL & …, 2023 - flore.unifi.it
BackgroundApproximately 20-50% of patients presenting with localized colorectal cancer
progress to stage IV metastatic disease (mCRC) following initial treatment and this is a major …
progress to stage IV metastatic disease (mCRC) following initial treatment and this is a major …
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids.
M Cioce, MR Fumagalli, S Donzelli… - … of Experimental & …, 2023 - search.ebscohost.com
Abstract Background: Approximately 20–50% of patients presenting with localized colorectal
cancer progress to stage IV metastatic disease (mCRC) following initial treatment and this is …
cancer progress to stage IV metastatic disease (mCRC) following initial treatment and this is …
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids
M Cioce, MR Fumagalli, S Donzelli… - … of Experimental and …, 2023 - search.proquest.com
Background Approximately 20–50% of patients presenting with localized colorectal cancer
progress to stage IV metastatic disease (mCRC) following initial treatment and this is a major …
progress to stage IV metastatic disease (mCRC) following initial treatment and this is a major …
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids
M Cioce, MR Fumagalli, S Donzelli, F Goeman… - … OF EXPERIMENTAL & …, 2023 - air.unimi.it
Background: Approximately 20-50% of patients presenting with localized colorectal cancer
progress to stage IV metastatic disease (mCRC) following initial treatment and this is a major …
progress to stage IV metastatic disease (mCRC) following initial treatment and this is a major …
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids
M Cioce, MR Fumagalli, S Donzelli… - JOURNAL OF …, 2023 - iris.unicampus.it
Abstract BackgroundApproximately 20-50% of patients presenting with localized colorectal
cancer progress to stage IV metastatic disease (mCRC) following initial treatment and this is …
cancer progress to stage IV metastatic disease (mCRC) following initial treatment and this is …
[HTML][HTML] Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived …
M Cioce, MR Fumagalli, S Donzelli… - … of Experimental & …, 2023 - ncbi.nlm.nih.gov
Background Approximately 20–50% of patients presenting with localized colorectal cancer
progress to stage IV metastatic disease (mCRC) following initial treatment and this is a major …
progress to stage IV metastatic disease (mCRC) following initial treatment and this is a major …
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids
M Cioce, MR Fumagalli, S Donzelli… - … of experimental & …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Approximately 20-50% of patients presenting with localized colorectal cancer
progress to stage IV metastatic disease (mCRC) following initial treatment and this is a major …
progress to stage IV metastatic disease (mCRC) following initial treatment and this is a major …
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids
M Cioce, MR Fumagalli, S Donzelli… - Journal of experimental …, 2023 - hal.science
Abstract Background Approximately 20–50% of patients presenting with localized colorectal
cancer progress to stage IV metastatic disease (mCRC) following initial treatment and this is …
cancer progress to stage IV metastatic disease (mCRC) following initial treatment and this is …